Position in GMAB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,033,778
+$36,695 QoQ
Shares Held
37,633
+1.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#98
of 291 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GRANDFIELD & DODD, LLC holds $46,143,038 across 12 Biotechnology names. GMAB ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,628 | $22,839,023 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,838 | $12,337,779 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
37,077 | $2,939,835 | |
| 4 | INCY |
Incyte Corp
|
20,822 | $2,360,381 | |
| 5 | EXEL |
Exelixis, Inc.
|
27,109 | $1,475,000 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
18,243 | $1,043,864 | |
| 7 | GMAB |
Genmab A/S
This page
|
37,633 | $1,033,778 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,204 | $964,500 |
All Filings in GMAB
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,033,778 | 37,633 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $997,083 | 37,163 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,173,418 | 38,098 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,200,209 | 39,133 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $795,471 | 38,503 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $781,104 | 39,893 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $704,007 | 33,733 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $789,009 | 32,363 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $647,172 | 25,753 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $790,162 | 26,418 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $813,766 | 25,558 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $881,503 | 24,993 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $825,121 | 21,708 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $810,254 | 21,458 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $852,600 | 20,118 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $328,047 | 10,210 | Shares | Sole | 2022-11-04 | |
| No filing history on record for this holder in this stock. | ||||||